The role of alprazolam for the treatment of panic disorder in Australia

@article{Moylan2012TheRO,
  title={The role of alprazolam for the treatment of panic disorder in Australia},
  author={S. Moylan and F. Giorlando and Trond Nordfj{\ae}rn and M. Berk},
  journal={Australian & New Zealand Journal of Psychiatry},
  year={2012},
  volume={46},
  pages={212 - 224}
}
  • S. Moylan, F. Giorlando, +1 author M. Berk
  • Published 2012
  • Medicine
  • Australian & New Zealand Journal of Psychiatry
  • Objective: To investigate the potential impact of increasing prescription rates of alprazolam for the treatment of panic disorder (PD) in Australia through a review of efficacy, tolerability and adverse outcome literature. Methods: Data were sourced by a literature search using MEDLINE, Embase, PsycINFO and a manual search of scientific journals to identify relevant articles. Clinical practice guidelines from the American Psychiatric Association, National Institute of Clinical Excellence, Royal… CONTINUE READING
    Reconsidering benzodiazepines in the treatment of panic disorder
    • 5
    • Highly Influenced
    Alprazolam Dependence – The Sting in the Tail: A Case Report
    • 1
    • PDF
    Anxiety

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 131 REFERENCES
    Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
    • 99
    • Highly Influential
    Discontinuation reactions to alprazolam in panic disorder.
    • 27
    • Highly Influential
    Discontinuation of Alprazolam after successful treatment of panic disorder: a naturalistic follow-up study
    • 10
    • Highly Influential
    • PDF
    Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
    • 465
    • Highly Influential
    Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    • 139
    Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    • 203
    • Highly Influential
    Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?
    • 103